ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA
Clinical trials for ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA explained in plain language.
Never miss a new study
Get alerted when new ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA trials appear
Sign up with your email to follow new studies for ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug IC14 targets heart inflammation in rare condition
Disease control CompletedThis early-phase study tested a drug called IC14 in one person with arrhythmogenic cardiomyopathy, a rare heart condition that can cause dangerous rhythms. The goal was to see if the drug is safe and reduces inflammation, which may help control the disease. Participants received …
Matched conditions: ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA
Phase: PHASE1, PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Heart cell DNA test could improve rare disease diagnosis
Knowledge-focused CompletedThis study looked at whether DNA taken from heart muscle cells during a routine heart mapping procedure can be used to diagnose arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare heart condition. Researchers tested 34 adults to see if they could collect good-quality D…
Matched conditions: ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC